Serum Vaspin Concentrations in Human Obesity and Type 2 Diabetes

  1. Byung-Soo Youn12,
  2. Nora Klöting3,
  3. Jürgen Kratzsch4,
  4. Namseok Lee1,
  5. Ji Woo Park1,
  6. Eun-Sun Song1,
  7. Karen Ruschke3,
  8. Andreas Oberbach3,
  9. Mathias Fasshauer3,
  10. Michael Stumvoll3 and
  11. Matthias Blüher3
  1. 1AdipoGen, College of Life Science and Biotechnology, Korea University, Seoul, Korea
  2. 2Immunomodulation Research Center, University of Ulsan, Ulsan, Korea
  3. 3Department of Medicine, University of Leipzig, Leipzig, Germany
  4. 4Institute of Clinical Chemistry and Pathobiochemistry, University of Leipzig, Leipzig, Germany
  1. Address correspondence and reprint requests to Matthias Blüher, MD, University of Leipzig, Department of Medicine, Ph.-Rosenthal-Str. 27, 04103 Leipzig, Germany. E-mail: bluma{at}medizin.uni-leipzig.de; or Byung S. Youn, PhD, Scientific Director, AdipoGen. E-mail: bsyoun{at}adipogen.com

Abstract

OBJECTIVE— Vaspin was identified as an adipokine with insulin-sensitizing effects, which is predominantly secreted from visceral adipose tissue in a rat model of type 2 diabetes. We have recently shown that vaspin mRNA expression in adipose tissue is related to parameters of obesity and glucose metabolism. However, the regulation of vaspin serum concentrations in human obesity and type 2 diabetes is unknown.

RESEARCH DESIGN AND METHODS— For the measurement of vaspin serum concentrations, we developed an enzyme-linked immunosorbent assay (ELISA). Using this ELISA, we assessed circulating vaspin in a cross-sectional study of 187 subjects with a wide range of obesity, body fat distribution, insulin sensitivity, and glucose tolerance and in 60 individuals with normal glucose tolerance (NGT), impaired glucose tolerance (IGT), or type 2 diabetes before and after a 4-week physical training program.

RESULTS— Vaspin serum concentrations were significantly higher in female compared with male subjects. There was no difference in circulating vaspin between individuals with NGT and type 2 diabetes. In the normal glucose-tolerant group, circulating vaspin significantly correlated with BMI and insulin sensitivity. Moreover, physical training for 4 weeks resulted in significantly increased circulating vaspin levels.

CONCLUSIONS— We found a sexual dimorphism in circulating vaspin. Elevated vaspin serum concentrations are associated with obesity and impaired insulin sensitivity, whereas type 2 diabetes seems to abrogate the correlation between increased circulating vaspin, higher body weight, and decreased insulin sensitivity. Low circulating vaspin correlates with a high fitness level, whereas physical training in untrained individuals causes increased vaspin serum concentrations.

Footnotes

  • Published ahead of print at http://diabetes.diabetesjournals.org on 8 November 2007. DOI: 10.2337/db07-1045.

  • Additional information for this article can be found in an online appendix at http://dx.doi.org/10.2337/db07-1045.

  • B.-S.Y. and N.K. contributed equally to this work.

  • The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

    • Accepted November 3, 2007.
    • Received July 28, 2007.
« Previous | Next Article »Table of Contents

This Article

  1. Published online before print November 8, 2007, doi: 10.2337/db07-1045 Diabetes February 2008 vol. 57 no. 2 372-377
  1. » Abstract
  2. Full Text
  3. Full Text (PDF)
  4. All Versions of this Article:
    1. db07-1045v1
    2. 57/2/372 most recent

Current Issue

  1. December 2009, 58 (12)
    Current Issue
  1. Alert me to new issues of Diabetes